NHD Global
Host-defence peptides such as the cathelicidin-derived LL-37 and the tripeptide KPV are studied for membrane-active and immunomodulatory properties.
Thymic peptides in this section are used in immune-function research. This group draws on sequences catalogued under several product categories.
Continue from catalog navigation into editorial analysis, evidence records and quality-documentation guidance.
Showing 1–6 of 6 reviewed articles · Page 1 of 1
KPV is the tripeptide Lys-Pro-Val and corresponds to the C-terminal tripeptide of α-melanocyte-stimulating hormone. The short name does not specify salt, terminal…
Lire la revue des sources →KPV research spans keratinocyte stress models and targeted colon-delivery systems. The published effects are preclinical, and FDA states that it has not…
Lire la revue des sources →Thymalfasin is synthetic thymosin alpha-1: a defined 28-amino-acid peptide with an N-terminal acetyl group. Sequence and acetylation are part of identity, not…
Lire la revue des sources →The 2025 TESTS trial is more informative than earlier small sepsis reports: 1,106 adults were randomized across 22 centers, and thymosin alpha-1…
Lire la revue des sources →“LL-37” can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one…
Lire la revue des sources →A frequently cited LL-37 paper examined expression in human ocular-surface cells and antimicrobial activity in laboratory assays. It did not administer LL-37…
Lire la revue des sources →If a target is not listed, submit the sequence, scale and specification for a custom-project feasibility review.
Indiquez-nous vos besoins. Votre demande sera transmise à l’interlocuteur compétent pour les références, la disponibilité et les détails du devis.
